Ukraine pharma CEO urges the industry to rally behind his country on 3 frontsnews2022-03-07T15:29:04+00:00March 7th, 2022|Fierce Pharma|
Moderna taps Kenya as site for $500M mRNA manufacturing facilitynews2022-03-07T15:06:27+00:00March 7th, 2022|Fierce Pharma|
Bluebird Bio has ‘doubts’ about continuing to do business through 2022, announces CFO resignationnews2022-03-07T14:24:10+00:00March 7th, 2022|Fierce Pharma|
Horizon taps MasterChef winner Christine Ha to add culinary marketing flair to vision disease awarenessnews2022-03-07T14:02:27+00:00March 7th, 2022|Fierce Pharma|
Eli Lilly, Boehringer Ingelheim’s Jardiance turns up heat on AstraZeneca’s Farxiga with broad EU heart failure approvalnews2022-03-07T13:50:13+00:00March 7th, 2022|Fierce Pharma|
Roche’s Vabysmo to offer ‘fierce competition’ to Regeneron’s Eylea, but a long market battle awaits: Spherixnews2022-03-07T13:14:10+00:00March 7th, 2022|Fierce Pharma|
In ultrafast FDA nod, Bristol Myers’ Opdivo catapults I-O therapy to pre-surgery lung cancer with first glimpse of key datanews2022-03-07T09:19:12+00:00March 7th, 2022|Fierce Pharma|
Rapper Chuck D, SU2C team with PatientPoint to bring colon cancer screening message to the exam roomnews2022-03-04T21:51:58+00:00March 4th, 2022|Fierce Pharma|
Slaoui will return $3.86M to GlaxoSmithKline after his dismissal for sexual harassmentnews2022-03-04T18:43:36+00:00March 4th, 2022|Fierce Pharma|
Evolus’ has something to smile about as neurotoxin Jeuveau’s 2021 sales swell 76%news2022-03-04T16:12:26+00:00March 4th, 2022|Fierce Pharma|
